| MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. | |
| | |
MedLine Citation:
|
PMID: 20550547 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pulmonary fibrosis is defined by an overgrowth of fibroblasts and extracellular matrix deposition, and results in respiratory dysfunction that is often fatal. It is the end stage in many chronic inflammatory interstitial lung diseases (ILD) such as sarcoidosis and idiopathic pulmonary fibrosis (IPF). The myeloid-related proteins (MRPs) belong to the S100 family of calcium-binding proteins and are highly expressed by neutrophils, macrophages and epithelial cells during chronic inflammation. MRP14 stimulates fibroblast proliferation in vitro and is expressed in granulomas from sarcoidosis patients. We hypothesized that MRP14 may be a biomarker for fibrotic interstitial lung diseases. The objective of this study was to investigate whether levels of MRP14 in the bronchoalveolar lavage fluid (BALF) of patients with sarcoidosis and IPF correlate with clinical parameters. We used an enzyme-linked immunosorbent assay (ELISA) to measure MRP14 in BALF of 74 sarcoidosis patients, 54 IPF patients and 19 controls. Mean BALF levels of MRP14 were elevated significantly in IPF (P < 0.001) and sarcoidosis (P < 0.05) patients compared to controls. MRP14 levels were associated linearly with sarcoidosis disease severity based on chest radiographic stage. Moreover, BALF MRP14 levels were correlated inversely with diffusion capacity and forced vital capacity in sarcoidosis patients. In IPF patients, a correlation with BALF neutrophil percentage was found. In conclusion, BALF MRP14 levels are elevated in IPF and sarcoidosis and are associated with disease severity in sarcoidosis. The results support the need for further studies into the role of MRP14 in the pathogenesis of lung fibrosis. |
| | |
Authors:
|
N M Korthagen; M M Nagtegaal; C H M van Moorsel; K M Kazemier; J M M van den Bosch; J C Grutters |
Related Documents
:
|
19154487 - Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous ple... 1156057 - Pericardial effusions in patients with malignant diseases. 17394687 - Outcomes of tuberculosis patients who start antiretroviral therapy under routine progra... 9789897 - Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of... 17150337 - Attentional networks and cingulum bundle in chronic schizophrenia. 19426637 - Preoperative evaluation for vascular access creation. |
Publication Detail:
|
Type: Journal Article Date: 2010-06-09 |
Journal Detail:
|
Title: Clinical and experimental immunology Volume: 161 ISSN: 1365-2249 ISO Abbreviation: Clin. Exp. Immunol. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-26 Completed Date: 2010-08-27 Revised Date: 2011-08-03 |
Medline Journal Info:
|
Nlm Unique ID: 0057202 Medline TA: Clin Exp Immunol Country: England |
Other Details:
|
Languages: eng Pagination: 342-7 Citation Subset: IM |
Affiliation:
|
Center for Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital Nieuwegein, the Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Biological Markers / analysis, metabolism Bronchoalveolar Lavage Fluid / chemistry*, cytology Calgranulin B / analysis, metabolism* Carbon Monoxide / metabolism Cell Count Female Forced Expiratory Volume / physiology Humans Idiopathic Pulmonary Fibrosis / metabolism, pathology, physiopathology Lung Diseases, Interstitial / complications, metabolism* Male Middle Aged Neutrophils / pathology Pulmonary Diffusing Capacity / physiology Pulmonary Fibrosis / etiology, metabolism* Sarcoidosis, Pulmonary / diagnosis, metabolism, physiopathology Vital Capacity / physiology Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Calgranulin B; 630-08-0/Carbon Monoxide |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosi...
Next Document: Association of NKG2A with treatment for chronic hepatitis C virus infection.